AUSTER MARTIN (Chief Financial Officer) sold 55.6% of their position (26.47K shares) of VENTYX BIOSCIENCES, INC. on the open market
Open‑market sale worth $863.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/7/2023ACC: 0001209191-23-048632
Officer· Chief Financial Officer
Since Oct 2021
-26.47K
Net shares
Net seller
$863.3K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
26.47K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−18.33K
Price / share
$32.26
Trade value
$591.18K
% of position
38.5%
9/5/2023
47.65K→29.32K
Common Stock
Direct
Shares
−8.14K
Price / share
$33.41
Trade value
$272.05K
% of position
27.8%
9/5/2023
29.32K→21.18K
Common Stock
Direct
Shares
−3.00
Price / share
$33.98
Trade value
$101.94
% of position
0.0%
9/5/2023
21.18K→21.18K
Total
Net shares
−26.47K
Net value
-$863.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/5/2023 | S · Sale | −18.33K | $32.26 | $591.18K | 38.5% | 47.65K | 29.32K |
| Common Stock Direct | 9/5/2023 | S · Sale | −8.14K | $33.41 | $272.05K | 27.8% | 29.32K | 21.18K |
| Common Stock Direct | 9/5/2023 | S · Sale | −3.00 | $33.98 | $101.94 | 0.0% | 21.18K | 21.18K |
| Total | −26.47K | -$863.33K | ||||||
Derivative Transactions0
No derivative transactions reported